UNIVERSITY OF OTAGO

New Zealand Universities Launch Clinical Trials Testing Psychedelics for Treatment-Resistant Mental Health Disorders

- University of Auckland and University of Otago are conducting clinical trials investigating psychedelic drugs for treatment-resistant mood disorders, including an eight-week LSD microdosing study. - Researchers are testing whether psychedelics at specific dosages can produce changes in brain activity that may improve mental health outcomes for patients who haven't responded to conventional treatments. - The trials represent a significant shift in psychiatric research, exploring alternative therapeutic approaches for conditions like anxiety and depression that affect substantial portions of the population. - Study leaders emphasize the importance of controlled clinical settings and caution against attributing therapeutic effects solely to the psychedelic compounds without proper scientific evaluation.